Voyager Therapeutics (VYGR) Change in Acquisitions & Divestments (2015 - 2026)

Voyager Therapeutics has reported Change in Acquisitions & Divestments for 12 years, with the latest figure at $51.6 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 56.6% year-over-year to $51.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $336.8 million (up 14.46% YoY) and the FY2025 annual result came in at $262.0 million, down 30.02% from the prior year.
• Change in Acquisitions & Divestments fell to $51.6 million in Q1 2026 per VYGR's latest filing, from $118.8 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $118.8 million in Q1 2025 and troughed at $5.0 million in Q2 2023.
• A 5-year average of $47.6 million and a median of $33.3 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2024 and 2026: Change in Acquisitions & Divestments soared 632.85% in 2024, then slumped 56.6% in 2026.
• Over 5 years, Change in Acquisitions & Divestments stood at $15.0 million in 2022, then jumped by 277.21% to $56.6 million in 2023, then jumped by 94.28% to $109.9 million in 2024, then advanced by 8.06% to $118.8 million in 2025, then plunged by 56.6% to $51.6 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $51.6 million, $118.8 million, and $109.9 million for Q1 2026, Q1 2025, and Q1 2024 respectively.